The weekly litigation news digest is live. Subscribe now

IP Verse

Methods For Therapeutic Administration Of Messenger Ribonucleic Acid Drugs - EP3359670

The patent EP3359670 was granted to Moderna on Feb 14, 2024. The application was filed on Oct 5, 2016 under application number EP16782372A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3359670

MODERNA
Application Number
EP16782372A
Filing Date
Oct 5, 2016
Status
Patent Maintained As Amended
Jan 12, 2024
Publication Date
Feb 14, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
WITHERS & ROGERSFeb 12, 2021TOMBLINGADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTEP2221371
INTERNATIONAL-SEARCH-REPORTWO2006128245
INTERNATIONAL-SEARCH-REPORTWO2012056440
INTERNATIONAL-SEARCH-REPORTWO2013131143
INTERNATIONAL-SEARCH-REPORTWO2014140856
INTERNATIONAL-SEARCH-REPORTWO2014152540
INTERNATIONAL-SEARCH-REPORTWO2014159813
INTERNATIONAL-SEARCH-REPORTWO2015073884
OPPOSITIONWO2013090648
OTHERUS2014147454
OTHERUS9597380
OTHERWO2011012316
OTHERWO2013090648

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents